Pfizer announced progress in developing a once-daily version of its weight loss pill, Danuglipron. Encouraging early-stage study results led the company to identify a favorable formulation regarding safety and bodily response. Further trials are planned for later this year to determine the optimal dose, with results expected in the first quarter of next year. Notably,…
A detailed pharmacovigilance investigation conducted by Kyung Hee University and Ajou University aimed to identify predictors associated with an increased risk of serious adverse events (SAEs) related to anti-obesity medications and to provide crucial evidence on drug safety. The Study The study analyzed 13,766 side effect reports from 2010 to 2019, uncovering important insights into…
New research from December 2023 indicates that adherence to anti-obesity medications remains a major challenge, with the vast majority of patients discontinuing treatment within one year. However, newer drugs like Wegovy are showing higher rates of long-term usage that may improve health outcomes. Research Shows 80% Discontinue Treatment by One Year According to new research…
A recent study published in 2023 investigated the cost-effectiveness of various anti-obesity medications for adolescents (). Given the rising prevalence of childhood and teen obesity, identifying affordable and efficient treatments is crucial. The Study Researchers from Columbia University and the University of Minnesota developed a microsimulation model to evaluate costs, health outcomes, and body mass…
As shortages of hot new weight-loss drugs like Ozempic and Wegovy persist due to surging consumer demand, patients are increasingly exploring older, time-tested alternatives that have stood the test of time. The Allure of the Next Big Thing The pharmaceutical world is witnessing a notable shift in prescription trends due to the scarcity of popular…
Type 2 diabetes is a chronic disease that has become more prevalent, with the number of people suffering from the condition estimated to be 422 million as of 2014 (). Diabetes is significantly linked to obesity and high blood pressure. This relationship is of great interest to researchers, and a recent study was carried out…
The Centers for Disease Control and Prevention (CDC) says that being overweight or having obesity increases the risk of getting cancer . To reduce this risk, it’s essential to maintain a healthy weight. But it is unknown whether overweight and obese people can reduce the risk of getting cancer through intentional weight loss. Thanks to…
It is common knowledge that physical activity is essential for general well-being. However, many people are not getting enough exercise. The reasons for physical inactivity range from physical to environmental barriers (). Individuals concerned about their lack of physical activity try many options to become more active. One of such options includes using wearable and…
Unhealthy lifestyle habits such as not getting enough sleep or physical activity are known to increase the risk of obesity and overweight. But it is unknown whether increasing sleep duration can reverse or prevent obesity. As a result, researchers are interested in whether adequate sleep can be an effective long-term weight strategy for obese and…
Calorie deficit, eating and drinking fewer calories than what the body burns, is a proven method of losing weight (). Many diets have been designed to achieve calorie deficits, with some of them referred to as extreme diets. Such diets attain extreme calorie deficits by reducing calorie intake to only 1000 calories a day ()….